SOUTH SAN FRANCISCO, Calif., April 03, 2017 (GLOBE NEWSWIRE) — Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced that a poster featuring data related to Five Prime’s unique discovery platform was presented today at the 2017 American Association for Cancer Research (AACR) Annual Meeting ...
The post Five Prime Presents Data on Unique Immuno-Oncology Discovery Research at the 2017 AACR Annual Meeting appeared first on ForexTV.
April 03, 2017 at 10:08PM
http://ift.tt/2otY5rE
from Nasdaq NewsFeed
http://ift.tt/2otY5rE
No comments:
Post a Comment